Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Wiskott-Aldrich syndrome

H D Ochs1

  • 1Department of Pediatrics, University of Washington School of Medicine, Seattle 98195-6320, USA.

Seminars in Hematology
|November 4, 1998
PubMed
Summary

Wiskott-Aldrich syndrome (WAS) is an X-linked disorder characterized by immune defects and thrombocytopenia. Identifying the WAS protein (WASP) gene enables molecular diagnosis and guides treatment strategies like stem cell transplantation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

7th International Immunoglobulin Conference: Immunodeficiencies.

Clinical and experimental immunology·2014
Same author

Common variable immunodeficiency (CVID): new genetic insight and unanswered questions.

Clinical and experimental immunology·2014
Same author

7th International Immunoglobulin Conference: Immunodeficiencies.

Clinical and experimental immunology·2014
Same author

Efficacy and safety of home-based subcutaneous immunoglobulin replacement therapy in paediatric patients with primary immunodeficiencies.

Clinical and experimental immunology·2011
Same author

Structure and function of the gastrointestinal tract in primary immunodeficiency syndromes. A study of 39 patients.

Medicine·2010
Same author

Immunodeficiencies.

Clinical and experimental immunology·2009

Area of Science:

  • Immunology
  • Genetics
  • Hematology

Background:

  • Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder presenting with congenital thrombocytopenia, eczema, and recurrent infections.
  • Immune defects in WAS include lymphopenia, impaired antibody production, and defective cell-mediated immunity.
  • A milder allelic variant, hereditary X-linked thrombocytopenia (XLT), shares the same genetic basis.

Purpose of the Study:

  • To review the clinical and molecular aspects of Wiskott-Aldrich syndrome (WAS) and hereditary X-linked thrombocytopenia (XLT).
  • To highlight the identification and function of the WAS protein (WASP) gene.
  • To discuss diagnostic and therapeutic advancements for WAS.

Main Methods:

  • Literature review of historical descriptions and genetic studies of WAS and XLT.
  • Analysis of the Wiskott-Aldrich syndrome protein (WASP) gene structure and expression.
  • Summary of current diagnostic approaches and treatment modalities.

Main Results:

  • WAS and XLT are caused by mutations in the same gene, WASP, located at Xp11.22.
  • WASP encodes a protein crucial for signal transduction and cytoskeletal regulation in hematopoietic cells.
  • Molecular diagnosis, carrier detection, and prenatal diagnosis are now feasible.

Conclusions:

  • The identification of the WASP gene has revolutionized the understanding and diagnosis of WAS.
  • Current treatments are largely symptomatic, but stem cell transplantation offers a curative option.
  • Further research into WASP function may reveal novel therapeutic targets.

Related Experiment Videos